- Who can participate: Eligible participants include adults aged 18 to 65 with a documented diagnosis of the condition under study. Key eligibility factors include specific health criteria and the absence of certain medical conditions.
- Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. They will undergo regular assessments to monitor their health and response to the treatment.